Repligen Income Statement
RGEN / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Revenue has grown at a 4.5% compound annual rate over the past 6 years.
Based on SEC 10-K filings.
Key Data Points
- Negative profit margin: -18.1%
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $30.6M | $104.5M | $68.2M | $63.5M | $68.2M | $62.3M | $23.5M |
| Cost of Revenue | $352.0M | $359.8M | $353.9M | $345.8M | $279.3M | $156.6M | $119.1M | $86.5M | $67.0M | $47.1M | $22.5M | $28.0M | $22.5M | $25.0M | $5.2M |
| Gross Profit | - | - | - | - | - | - | $33.8M | $25.2M | - | - | - | - | - | - | - |
| SG&A Expense | $290.5M | $263.4M | $218.6M | $215.8M | $183.9M | $119.6M | $95.6M | $65.7M | $51.5M | $30.9M | $12.7M | $17.2M | $12.7M | $13.2M | $9.1M |
| R&D Expense | $54.2M | $43.2M | $42.7M | $43.9M | $34.3M | $20.2M | $19.4M | $15.8M | $8.7M | $7.4M | $7.3M | $5.6M | $7.3M | $10.5M | $9.5M |
| Operating Income | $55.2M | -$35.1M | $47.7M | $224.7M | $167.2M | $69.8M | $36.1M | $26.0M | $14.0M | $16.0M | $22.9M | $10.7M | $22.9M | $11.1M | -$1.1M |
| Interest Expense | $22.6M | $21.8M | $10.0M | $1.2M | $11.3M | $10.8M | $9.3M | $6.7M | $6.4M | $3.8M | $50.0K | $50.0K | $50.0K | $56.7K | $27.8K |
| Income Tax | $13.5M | -$1.5M | $21.1M | $33.2M | $25.3M | -$709.0K | $4.7M | $4.8M | -$21.1M | $11.0K | $6.9M | $3.0M | $6.9M | -$2.9M | $15.7K |
| Net Income | $48.9M | -$25.5M | $35.6M | $186.0M | $128.3M | $59.9M | $21.4M | $16.6M | $28.4M | $11.7M | $16.1M | $8.2M | $16.1M | $14.2M | -$1.6M |
| EPS (Basic) | $0.87 | -$0.46 | $0.64 | $3.35 | $2.33 | $1.14 | $0.44 | $0.38 | $0.28 | $0.25 | $0.51 | $0.46 | $0.06 | $0.06 | -$0.13 |
| EPS (Diluted) | $0.86 | -$0.46 | $0.63 | $3.24 | $2.24 | $1.11 | $0.44 | $0.37 | $0.28 | $0.25 | $0.50 | $0.45 | $0.06 | $0.06 | -$0.13 |
| Shares Outstanding | 56.6K | 55.9K | 56.4K | 57.5K | 57.3K | 53.9K | 49.2M | 45.5M | 33.8M | 32.9M | 32.8M | 31.9M | 31.2M | 30.7M | 30.8M |
| Operating Margin | - | - | - | - | - | - | - | - | 45.8% | 15.3% | 33.6% | 16.8% | 33.6% | 17.8% | -4.7% |
| Profit Margin | - | - | - | - | - | - | - | - | 92.7% | 11.2% | 23.6% | 12.9% | 23.6% | 22.7% | -6.9% |